Home » Newsletters » BioWorld Science

BioWorld Science

April 14, 1997

View Archived Issues

Pfizer reports new salt of known NMDA antagonist

PEP inhibitors from Chinoin

Fournier discloses bradykinin antagonists

Astra reveals novel opioid peptides

Novel heterocyclic 5-HT1B receptor antagonists disclosed by SKB

Antioxidants/sodium channel blockers from Takeda

University of Michigan researchers describe anti-HCMV agents

Orally active GH secretagogues reported by Lilly

Novartis describes small-molecule signal transduction inhibitors

Takeda reveals endothelin antagonists

Integrilin MAA withdrawn; companies await PURSUIT results

Tentative approval for Faulding's generic aciclovir for injection

Development of Auriculin suspended

Immunex's Enbrel demonstrates positive safety profile in RA patients

Scherer granted U.S. patent for ascorbic acid in softgel delivery system

First CFC-free inhaler launched in U.S.

Immunogene therapy for cancer enters clinical trials

Pharmacia & Upjohn introduces new GH delivery device

Positive results with Viracept combination therapy

FK-633 inhibits thrombosis and prevents restenosis in hamster model

Gilead's PMPA reduces HIV levels in clinical trials

Preclinical studies indicate potential of TAK-147 for AD

ABT-761 reduces bronchoconstriction and pulmonary inflammation in animals

Roberts' Agrylin available today in U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...